chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had the shots/Suspected Vaccination Failure; Also had it on his face; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Had the shots/Suspected Vaccination Failure) (serious criteria GSK medically significant) and shingles (Verbatim: Also had it on his face). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 11-MAR-2023 The case was received from the consumer via interactive digital media. The reporter stated that patient (another person) who showed up at the physician office also had it on his face and had the Shingles shots, though his case was much worse than reporter. The physician even made a comment that he had never seen anyone who had the shots and then had them on their face and might be something missing in the vaccine that was causing this to happen. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. This case is linked with US2023AMR041949, reported by same reporter.; Sender's Comments:  US-GSK-US2023AMR041949:same reporter
Shortly after my vaccine I developed  exercise induced asthma .  It seemed to get better until  I had my booster and then I developed high blood pressure and high cholesterol.   My cholesterol went form 160 to 207.
full bladder feeling/ feeling a need to urinate; having excessive urination; injection sites felt hard; This spontaneous case was reported by a consumer and describes the occurrence of POLLAKIURIA (full bladder feeling/ feeling a need to urinate), URINE OUTPUT INCREASED (having excessive urination) and VACCINATION SITE INDURATION (injection sites felt hard) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced POLLAKIURIA (full bladder feeling/ feeling a need to urinate), URINE OUTPUT INCREASED (having excessive urination) and VACCINATION SITE INDURATION (injection sites felt hard). At the time of the report, POLLAKIURIA (full bladder feeling/ feeling a need to urinate), URINE OUTPUT INCREASED (having excessive urination) and VACCINATION SITE INDURATION (injection sites felt hard) outcome was unknown.            Patient was sensitive to sodium and suspects the sodium in vaccine. No concomitant medications were reported. No treatment medications were reported   This case was linked to MOD-2021-319620, MOD-2021-319619 (Patient Link).   Reporter did not allow further contact
Second vaccine: immediately light headed, within 24 hours: headache, fever 102 degrees X 4 days, extreme muscle pain, swollen lymph nodes under left arm at day 5 and for 2 weeks, then intermittently for 5 months. Third vaccine: immediately light headed, within 3 hours migraine-like headache and minor aches. Within 24 hours 103 degree fever, lump on right arm at injection site, swollen painful lymph nodes under right arm down ribs, large muscle pain, joint pain.
they had gotten COVID-19 after receiving two primary and one booster dose of Comirnaty (BionTech/Pfizer COVID-19 vaccine).; they had gotten COVID-19 after receiving two primary and one booster dose of Comirnaty (BionTech/Pfizer COVID-19 vaccine).; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47-year-old female patient received BNT162b2 (COMIRNATY), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "they had gotten COVID-19 after receiving two primary and one booster dose of Comirnaty (BionTech/Pfizer COVID-19 vaccine).". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: COVID-19, notes: Reporter stated they had gotten COVID-19 after receiving two primary and one booster dose of Comirnaty (BionTech/Pfizer covid-19 vaccine).Reporter acknowledged minor symptoms, no hospitalization.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pain in legs; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 24Apr2021 10:30 (Lot number: EW0172) at the age of 64 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "High blood pressure" (unspecified if ongoing); "High cholesterol" (unspecified if ongoing). Concomitant medication(s) included: ATORVASTATIN; AMLODIPINE; LISINOPRIL. Past drug history included: Codeine, reaction(s): "Known allergies: Codeine". The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 26Apr2021, outcome "not recovered", described as "pain in legs". The event "pain in legs" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pain in extremity.  Additional Information: The adverse event was treated with steroid shot and prescription of Prednisone 10mg. Prior vaccination, the patient had no covid. The patient tested covid post vaccination. The patient had no other vaccine in four weeks.  Follow-up attempts completed. No further information expected.
Headache, Myalgia, Arthralgia, Fever, Diarrhea & NauseaVomiting Narrative:
welt; fatigue, tiredness; This case was reported by a other health professional via call center representative and described the occurrence of welts in a 52-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th January 2022, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced welts and fatigue. On an unknown date, the outcome of the welts and fatigue were unknown.   It was unknown if the reporter considered the welts and fatigue to be related to Shingrix.     Linked case(s) involving the same patient:  US2022073178   Additional Information: GSK Receipt Date: 03-MAY-2022 Reporter's Comments: The reporter stated that the patient received Shingrix and experienced a welt, fatigue and tiredness. The reporter was unable to provide full vaccine details. The reporter did not consent to follow-up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022073178:same reporter
5/24/21: Started with face numbness on left side, eye twitch, below neck full body numbness (pins and needles) lasted over a week, then just went to my legs, feet, fingers. Foot and legs cramps at night, swollen red toes.  Around 6/1/21 toes on both feet became extremely red and painful, as well as the pads of my feet (hot to the touch). Walking and driving became painful and difficult. Nothing could be touching my toes/feet because of the severe pain. Random Jots would go from my feet up through my body. Sleeping became impossible because of the pain. 6/7/21 contacted a Dr. prescribed me METHYLPREDNISOLONE 4 MG DOSEPK. This had no affects to the pain swelling went down in toes. I then scheduled an appointment with a podiatrist 6/21/21. She prescribed another METHYLPREDNISOLONE 4 MG DOSEPK. Followed back up and feet were more red. She advised me to get labs done. Later that day I had acupuncture to treat toes. next two appointments for acupuncture 6/24/21, 6/28/21. Pins in needles were gone other than my feet, toes, right fingers. As of now my left foot /toes are not as painful. Numbness/pins&needles. Right toes and pad of foot are still numb with pins&needles.
Pale, listless, blue lips, irritable, shallow breathing for 3 days after shots.
Patient reports she had arm soreness a day after vaccine that subsided. On 12/6/21 in the am she awoke with redness around the vaccine site and itching. No warmth, mild tenderness and mild swelling. She tried some unmedicated cream without relief and took ibuprofen. Symptoms remained unchanged and she came in on 12/8/21 to be seen. I advised the patient to try cool compresses, ibuprofen and OTC zyrtec for itching for 1-2 days and if no improvement or if she develops pain, spread of redness or no improvement to take oral antibiotics as directed. I prescribed a course of dicloxacillin and will check on the patient in 2 days.
c/o swollen tongue, tingling in left arm, swollen feeling resolved after 19 minutes
Hospitalized 12/5/2021; COVID-19 positive 12/5/2021; fully vaccinated  BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 12/5/2021 Discharge Date: 12/07/2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: AKI (acute kidney injury) (HCC) [N17.9] Acute respiratory failure with hypoxia (HCC) [J96.01] Acute hypoxemic respiratory failure due to COVID-19 (HCC) [U07.1, J96.01] COVID [U07.1]   HOSPITAL COURSE: Patient is a 71-year-old male who presented to the emergency department with fatigue and cough.  In the emergency department, patient was tachycardic and found to be hypoxemic on room air and placed on supplemental oxygen.  Chest x-ray showed minimal hazy and streaky opacities seen in the inferior lateral left lung which can be seen with COVID 19 pneumonia.  Patient was positive for COVID-19.  He was admitted.  He was started on Decadron and remdesivir.  Patient improved during his hospital stay.  He was able to be weaned from supplemental oxygen.  PT/OT evaluated patient recommended home with assist.  Patient was recommended to increased testing of blood sugars at home while on Decadron into call PCP with elevated sugars.  Patient was recommended follow-up with primary care physician.  He was discharged home in stable condition.
Mom called 10/21/02 stating that on morning of 10/19/02 patient got blister like spot at sight of chicken pox vaccination with a large red spot around it. Patient now also has eight red spots on abdomen. Advised mother to take him to see family physician today.
prevnar 13 was adminsitered IM into patient left arm. left arm had mild-moderate swelling within seconds of administration. benadryl was given to help with swelling
I was about 4-5 weeks pregnant when I received this second dose. I was hesitant to get the second dose because I had heavy bleeding and passed clots with the first dose, which was not at all normal for me. Three days after I received the second dose, around 9pm, I started heavy bleeding and passing large clots. Similar to what happened the first shot except this time I was pregnant. So I went to the Emergency department and they did some bloodwork and test and diagnosed me with ?threatened miscarriage? but I had to get blood work in a few days to know for sure. So I went to my doctor and got blood work and it showed that I was indeed having a miscarriage from this second vaccination. The bleeding only lasted 4 days and went away. Now it?s been almost two weeks since the bleeding stopped and I?m starting to pass clots again which is something I have only ever experienced since receiving the first covid vaccine dose.
Tingling & soreness down her arm shortly after receiving the shot. Later that night she had stabbing pains in her chest that lasted several hours. She felt better the next day. Residual soreness for a total of 2 days.
This spontaneous report as received from a nurse refers to a 16 month old male patient. The patient's pertinent medical history, current conditions and concomitant medications were not reported. No previous drug reactions or allergies were reported. On 09-JUN-2016 the patient was vaccinated with expired M-M-R II (dosing details were not reported) (lot # K007106, expiry date 16-MAY-2016) subcutaneously in the left leg (expired vaccine used) . The patient has not experienced an adverse events. There was no product quality company involved. Additional information has been requested.
Mother stated the client developed a fever the evening following the injection. She took his temperature orally with a mercury thermometer, it was 104 degrees F. She did give him aspirin and later realized that she should not have done this because of the associated risk of Reyes Syndrome. She also put him in the bath tub. She reports that his temp was down to 102 degrees F within 20 minutes and then down further relatively quickly. She gave him Motrin the rest of the night, no more aspirin. No other symptoms to report.
Patient was administered only half dose (0.25 milliliters) of the recommended (0.5 milliliters) Moderna bivalent dose. No adverse reactions reported.
incorrect  pfizer covid 19 vaccine administered - should have been pfizer covid 19 bivalent
J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 9/7/2022 HYPONATREMIA R09.02 HYPOXIA 9/7/2022 HYPONATREMIA J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 9/7/2022 ACQUIRED SCHATZKIS RING R09.02 HYPOXIA 9/7/2022 ACQUIRED SCHATZKIS RING J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 9/7/2022 MEDIASTINAL LYMPHADENOPATHY R09.02 HYPOXIA 9/7/2022 MEDIASTINAL LYMPHADENOPATHY J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 9/7/2022 HYPONATREMIA R09.02 HYPOXIA 9/7/2022 HYPONATREMIA J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 9/7/2022 HYPONATREMIA R09.02 HYPOXIA 9/7/2022 HYPONATREMIA J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 9/7/2022 MELENA R09.02 HYPOXIA 9/7/2022 MELENA
SHORT ASTHMA SYMPTOM, A FEW HIVES OVER WEEKEND. FATIGUE AND BODY ACHES PROGRESSING THROUGH TO 11/11 WITH THROBBING PAIN IN LEFT ARM (INJECTION ARM) AND DOWN INTO SHOULDER BLADE. STILL SOME BODY ACHES ON 11/12 BUT MUCH IMPROVED.
Patient tested positive for COVID-19 on 1/20/21. I was advised to report this as an adverse effect for vaccine efficacy.
PT STATED HE HAD SWELLING IN THE ARM WHERE VACCINE WAS GIVEN AND THAT HIS LIPS STARTED TO SWELL UP. RECOMMENDED PT TO TAKE BENADRYL UNTIL SYMPTOMS RESOLVE, IF NOT GO TO DR.
Received an expired ACTHIB vaccine. No adverse effects. Dose not effective and will need to be repeated.
Itchy rash that looks like hives surrounding injection site location- upper right arm only. No previous rash noted after receiving the vaccine, then suddenly it developed today (day 9 post-dose). I had mild symptoms - fatigue, injection site pain, arm and armpit discomfort for several days following the vaccine but this resolved after a few days.  No other symptoms currently, other than the new rash.
SORE ARM; This spontaneous report received from a patient via a company representative concerned a 63 year old of unspecified sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) dose, start therapy date were not reported for an unspecified indication. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of pain in arm was not reported. This report was non-serious.
she began having slight issues with her scalp/get these things off of her head (red, look like shingles); she began having slight issues with her scalp/get these things off of her head (red, look like shingles); flu symptoms; This spontaneous report was received from an 80-year-old female patient referring to herself. Information about medical history, concurrent conditions and concomitant therapies was not provided.    In October 2015, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (1 time injection; strength, dose, route, lot # and expiration date were not reported) for preventative.         In 2015 (by the end of the year), the patient began having slight issues with her scalp, she had to begin cutting her own hair after she would get these things off of her head (red, look like shingles). The patient had been going to numerous physicians (primary care, infectious disease, ear nose throat (ENT), dermatologist and none of them had been able to solve her problem. This had been ongoing for 5 and a half years and it just dawned on the patient recently that it might be from the vaccine since it started right after getting the vaccine, none of the physicians knew it might be a reaction of the vaccine and now she would try to give that information to one of the physicians to hopefully resolve the issue with her scalp. In 2015, the patient also got flu symptoms, she would get over it and then got the flu symptoms again. The patient sought medical attention, biopsy, swab, labs/tests were performed. The outcome of the events was reported as not recovered. The consumer considered red, look like shingles to be related to zoster vaccine live (ZOSTAVAX). Causality assessment between event flu symptoms and zoster vaccine live(ZOSTAVAX) was unknown.
Pt c/o swelling of her upper lip and eyelids and scratching sensation in her throat when she swallows started 2 hrs after getting flu vaccine.
swelling under her ear/ and along her jawline on the right side/ swelling along her jawline; This case was reported by a consumer via call center representative and described the occurrence of local swelling in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th March 2020, the patient received the 1st dose of Shingrix (intramuscular). On 13th March 2020, less than a day after receiving Shingrix, the patient experienced local swelling. The patient was treated with ibuprofen (Advil). On an unknown date, the outcome of the local swelling was recovered/resolved.   It was unknown if the reporter considered the local swelling to be related to Shingrix.  Additional details were reported as follows: The age at vaccination is not reported but it could be 73 years or 74 years. The patient received Shingrix in right arm and on same evening she noted swelling under her ear and along her jawline on the right side. The patient was advised to use Advil and warm compress on the area which helped and on the next day patient reported that the swelling had resolved. The reporter did not consent to follow up.
I received my second Moderna booster for COVID-19 on 4/12/2022. On 6/25/2022, I developed a runny nose, and it continued running for the next couple of days. I had just recently gotten back from a trip with my son. He called me to let me know that he had tested positive for COVID-19. On 6/27/2022, I took a home test for COVID-19, and I got a positive result. I called the clinic where I normally go and spoke to a NP. She tried to arrange for me to have a telemedicine appointment with a doctor, but none was available. She then suggested that I should go to a stand-alone clinic to obtain a prescription for Paxlovid. Since my symptoms weren't severe, though, I decided not to do this. She instructed me to stay home for 5 days. She told me that if I felt well enough after those 5 days were up, I could go out, but I should wear a mask. However, I stayed at home longer than 5 days before I got out. Along with the aforementioned runny nose, I had a little bit of sneezing, a slightly sore throat and a mild headache. I also felt more tired than usual and didn't have much energy. The symptoms altogether lasted maybe 5-6 days.
Narrative: Patient received one dose of the covid vaccine. Unclear cause of death. PMH included CAD, end stage asbestos lung disease. Limited details overall in chart. reporting per facility instructions.
48 hrs following influenza vaccination left deltoid developed erythema, edema and she noted all over muscle & joint pain and chills/night sweats. Sought her PCP's attention and was placed on a steroid dose pack and instructed to take anti-inflamatory of her choice (per phone conversation with nurse). As of today she is feeling much better, steroid tx is completed and she has no interest in taking another influenza vaccination in the future.
Presented to th emergency department with COVID-19 like symptoms, diagnosed with acute hypoxic respiratory failure related to COVID-19. became severely ill, tx with  Lovenox Remdesivir& Baricitinib did not improve-continuously getting deteriorated discharged to inpatient hospice.
Breakthrough case admission after 4 vaccines  Pfizer 2/9/21 Lot# EL9267;  Pfizer 3/2/21 Lot# EN6202'; 10/4/21  PFizer Lot# FE3592;  Pfizer 4/3/22 Lot# FJ9943
pt recvd vax 6DEC95 1150PM & 12:30 while eating exp severe pressure in chest,went upward to top of head,smelled ammonia & tasted ammonia type taste;had severe h/a became cold & shaking;mom called clinic instructed to call MD:
3 weeks almost 4,joint pain.Severe in hands and wrists..feet and ankles...elbows and knees less.But sharp hot shooting pain pain randomly in palms of hands and arch of feet a few times...also very fatigued...tired!
Severe  leg and lower back pain, leg muscle cramping in both legs, inflammation, difficulty standing, walking, sitting and completing everyday task.  Treatment prescribed Prednisone for inflammation and then took NSAIDs for another 2 weeks.
J96.91 HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 1/19/2022 URINARY RETENTION
Patient's wife called the pharmacy today (3/5) and stated that after receiving the vaccination patient did not feel well for a few days but that within a few days his blood pressure went up to 180/110. He was throwing up with a headache and ringing in his ears. He went in to his cardiologist and they said he had a heart murmur which had not been detected previously.  The cardiologist instructed the wife to let us (the pharmacy) know about the reaction which is what she did today. I am not sure which cardiologist the patient sees.
Shingrix/gven to 13 year old child; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 13-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.  Additional case details were reported as follows: The 13 year old patient was inadvertently given Shingrix vaccine, which led to inappropriate age at vaccine administration.   No other information was reported. The reporter could not provide any adverse event information on the patient. The reporter did not consented to follow up.
Patient said it was bleeding for 2 days then turned into deep bruising and pain down arm and under breast getting worse. Can't afford to go to MD. Will monitor and keep posted.
Approx 5 minutes after receiving vaccines, child and father walked to lobby and child fainted, striking his head on the floor.
pt recv vax 12JUL98 & during the inj pt exp pain & pressure;pt reported that the toxoid then exploded out of the base of needle;pt arm bled a lot;because amount toxoid given unk another 0.25ml was given;13JUL98 pt had cont pain neck;